474 related articles for article (PubMed ID: 32563898)
1. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
[TBL] [Abstract][Full Text] [Related]
2. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
Samanta D
Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
Montouris GD; Wheless JW; Glauser TA
Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
[TBL] [Abstract][Full Text] [Related]
5. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
[TBL] [Abstract][Full Text] [Related]
6. Lennox-Gastaut syndrome: a comprehensive review.
Asadi-Pooya AA
Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
[TBL] [Abstract][Full Text] [Related]
7. Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.
Dupont S; Banica-Wolters R; An-Gourfinkel I; Lambrecq V; Navarro V; Adam C; Nguyen-Michel VH
J Neurol; 2017 Jul; 264(7):1388-1396. PubMed ID: 28584915
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Slow-Spike-Wave Patterns with Maximal Discharges Contralateral to MRI Lesions Predict Better Surgical Prognosis in Symptomatic Lennox-Gastaut Syndrome or Lennox-Gastaut Phenotypes.
Yang MH; Liu J; Zhou YL; Yang H; Cai FC; Zempel J; Yang QW; Liu SY
Pediatr Neurosurg; 2020; 55(1):26-35. PubMed ID: 31851997
[TBL] [Abstract][Full Text] [Related]
9. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
[TBL] [Abstract][Full Text] [Related]
10. Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures.
Vignoli A; Oggioni G; De Maria G; Peron A; Savini MN; Zambrelli E; Chiesa V; La Briola F; Turner K; Canevini MP
Epilepsy Behav; 2017 Dec; 77():73-78. PubMed ID: 29126048
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
[TBL] [Abstract][Full Text] [Related]
12. Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.
Nightscales R; Chen Z; Barnard S; Auvrez C; Tao G; Sivathamboo S; Bennett C; Rychkova M; D'Souza W; Berkovic SF; Nicolo JP; O'Brien TJ; Perucca P; Scheffer IE; Kwan P
Epilepsia Open; 2024 Apr; 9(2):602-612. PubMed ID: 38135919
[TBL] [Abstract][Full Text] [Related]
13. Lennox Gastaut Syndrome - A strategic shift in diagnosis over time?
Evans NJ; Das K
Seizure; 2022 Dec; 103():68-71. PubMed ID: 36332460
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ
Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
[No Abstract] [Full Text] [Related]
15. Treatment of Lennox-Gastaut syndrome.
Hancock EC; Cross JH
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
[TBL] [Abstract][Full Text] [Related]
16. Rufinamide for the treatment of Lennox-Gastaut syndrome.
Besag FM
Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
[TBL] [Abstract][Full Text] [Related]
17. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
McCormack PL
Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Sharawat IK; Panda PK; Panda P; Dawman L
Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
[TBL] [Abstract][Full Text] [Related]
19. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
[TBL] [Abstract][Full Text] [Related]
20. Electroclinical pattern in the transition from West to Lennox-Gastaut syndrome.
Calvo A; Buompadre MC; Gallo A; Gutiérrez R; Valenzuela GR; Caraballo R
Epilepsy Res; 2020 Nov; 167():106446. PubMed ID: 32854045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
